{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:16:06Z","timestamp":1790698566846,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":5698,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:p>Twelve healthy volunteers received oral placebo, 250 mg of caffeine, and 500 mg of caffeine in a randomized, double\u2010blind, single\u2010dose crossover study. Caffeine kinetics were nonlinear, with clearance significantly reduced and elimination half\u2010life prolonged at the 500\u2010mg compared to the 250\u2010mg dose. The lower dose of caffeine produced more favorable subjective effects than the higher dose (elation, peacefulness, pleasantness), whereas unpleasant effects (tension, nervousness, anxiety, excitement, irritability, nausea, palpitations, restlessness) following the 500\u2010mg dose exceeded those of the 250\u2010mg dose. The lower dose of caffeine enhanced performance on the digit symbol substitution test and a tapping speed test compared to placebo; high\u2010dose caffeine produced less performance enhancement than the lower dose. The plasma concentration versus response relationship revealed concentration\u2010dependent increases in anxiety and improvements in cognitive and motor performance at low to intermediate concentrations. Both caffeine doses reduced electroencephalographic amplitude over the 4 Hz to 30 Hz spectrum, as well as in the alpha (8\u201311 Hz) and beta (12\u201330 Hz) ranges; however, effects were not dose\u2010dependent. While favorable subjective and performance\u2010enhancing stimulant effects occur at low to intermediate caffeine doses, the unfavorable subjective and somatic effects, as well as performance disruption, from high doses of caffeine may intrinsically limit the doses of caffeine used in the general population.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1997.tb04356.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T13:54:56Z","timestamp":1362750896000},"page":"693-703","source":"Crossref","is-referenced-by-count":315,"title":["Dose\u2010Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans"],"prefix":"10.1002","volume":"37","author":[{"given":"Gary B.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Ehrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill E.","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monette M.","family":"Cotreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerold S.","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard I.","family":"Shader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(95)00093-3"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(88)90107-X"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549010-00004"},{"key":"e_1_2_1_5_2","first-page":"213","volume-title":"Caffeine Coffee and Health","author":"B\u00e4ttig K","year":"1993"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(92)90012-B"},{"key":"e_1_2_1_7_2","first-page":"179","volume-title":"Human Psychopharmacology: Measures and Methods","author":"Lader MH","year":"1989"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00212836"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210153271601"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(90)90175-8"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(05)80202-7"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00345a001"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.5.3260"},{"key":"e_1_2_1_14_2","first-page":"145","article-title":"Caffeine\u2010induced behavioral stimulation is dose\u2010dependent and associated with A1 adenosine receptor occupancy","volume":"6","author":"Kaplan GB","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245786"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198710000-00004"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb02883.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00180102"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb00912.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244850"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0022-3565(25)24125-8","article-title":"Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity","volume":"248","author":"Kaplan GB","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244234"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90006-N"},{"key":"e_1_2_1_24_2","first-page":"215","article-title":"Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam","volume":"3","author":"Mattila M","year":"1988","journal-title":"Int Clin Pharmacol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90132-2"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790260027003"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820110031004"},{"key":"e_1_2_1_28_2","first-page":"90","article-title":"Quantitative electroencephalographic effects of caffeine in panic disorder","volume":"106","author":"Newman F","year":"1992","journal-title":"Psychiatry Res"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02253594"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3565(25)21328-3","article-title":"Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam","volume":"250","author":"Greenblatt DJ","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0022-3565(25)12284-2","article-title":"Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors, and clinical confirmation of a predicted interaction with ketoconazole","volume":"276","author":"Moltke LL","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106133242403"},{"key":"e_1_2_1_33_2","first-page":"1528,168","article-title":"The psychopharmacology of phenothiazine compounds","volume":"136","author":"DiMascio A","year":"1963","journal-title":"J Nerv Ment Dis"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(87)80463-2"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1991.tb03756.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90304-2"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.150"},{"key":"e_1_2_1_38_2","first-page":"182","article-title":"Dose\u2010dependent caffeine pharmacokinetics during severe sleep deprivation in humans","volume":"32","author":"Kamimori GH","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90025-X"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1988.tb01003.x"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1997.tb04356.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1997.tb04356.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T19:39:09Z","timestamp":1745955549000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1997.tb04356.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1002\/j.1552-4604.1997.tb04356.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1997.tb04356.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}